FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma.

Shaobo Wu Yuxia Liang Qijuan Zang Zixuan Xing Pan Yin Ruifang Sun Bingling Dai

Published in: Applied bionics and biomechanics (2022)

The discovery of mutant gene FLG as a biomarker of SKCM helps elucidate how changes in the immune environment promote the occurrence of cutaneous melanoma. Further analysis suggested that FLG might be a new predictor of SKCM prognosis.

Keyphrases

small molecule
risk assessment
genome wide
high throughput
copy number
soft tissue
gene expression
wound healing
dna methylation
genome wide identification